D Guyotat
- Hematology top 5%
- Acute Myeloid Leukemia Research 15
- Hematopoietic Stem Cell Transplantation 6
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 10
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management 4
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 7
-
- Neutropenia and Cancer Infections 5
-
- Acute Lymphoblastic Leukemia research 7
- Co-authors
- Lydia CamposD FièreE ArchimbaudPhilippe GainGilles ThuretCarmen AaneiBrigitte TardyN. Roubi
- Cited by
- HematologyGeneticsInternal Medicine
- Partner nations
- FranceSwitzerlandUnited States
In The Last Decade
D Guyotat
51 papers receiving 642 citations
Peers
Comparison fields: 5 of 71
- Hematology 274
- Genetics 153
- Internal Medicine 50
- Pathology and Forensic Medicine 142
- Oncology 121
Countries citing papers authored by D Guyotat
This map shows the geographic impact of D Guyotat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Guyotat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Guyotat more than expected).
Fields of papers citing papers by D Guyotat
This network shows the impact of papers produced by D Guyotat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Guyotat. The network helps show where D Guyotat may publish in the future.
Co-authorship network
The 25 scholars most cited alongside D Guyotat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 20 | |
| 2 | 2020 | 4 | |
| 3 | 2018 | 18 | |
| 4 | 2017 | 13 | |
| 5 | 2016 | 28 | |
| 6 | 2007 | 25 | |
| 7 | Long-term outcome of localized high-grade non-Hodgkin's lymphoma treated with high dose CHOP regimen and involved field radiotherapy: results of a GOELAMS study. | 2005 | 10 |
| 8 | 2004 | 3 | |
| 9 | 2003 | 12 | |
| 10 | 1999 | 1 | |
| 11 | 1998 | 50 | |
| 12 | 1997 | 21 | |
| 13 | [Thrombopenia induced by heparin: treatment with Org 10172. Tolerability and efficacy]. | 1996 | 3 |
| 14 | 1995 | 27 | |
| 15 | [Sweet syndrome in agranulocytosis. A pathogenic hypothesis]. | 1994 | 2 |
| 16 | 1992 | 7 | |
| 17 | Myeloid differentiation antigens identify leukemic cell subpopulations with different cell cycle characteristics. | 1990 | 8 |
| 18 | 1988 | 6 | |
| 19 | Culture of putative Langerhans cell bone marrow precursors: characterization of their phenotype. | 1988 | 26 |
| 20 | [Severe quantitative bone marrow insufficiency: results of treatment with high-dose antilymphocyte serum]. | 1985 | 1 |
About D Guyotat
D Guyotat is a scholar working on Hematology, Genetics and Internal Medicine, having authored 52 papers that have together received 659 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), Chronic Lymphocytic Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Hematopoietic Stem Cell Transplantation (6 papers), Neutropenia and Cancer Infections (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). The work is most often cited by research in Hematology (274 citations), Genetics (153 citations) and Internal Medicine (50 citations). D Guyotat has collaborated with scholars based in France, Switzerland and United States. Frequent co-authors include Lydia Campos, D Fière, E Archimbaud, Philippe Gain, Gilles Thuret, Carmen Aanei, Brigitte Tardy, N. Roubi, B. Tardy-Poncet and Hervé Decousus. Their work appears in journals such as Blood, Leukemia, Haematologica, Thrombosis Research and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.